14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 27, 2024 Sell 11 551 Jarrett Jennifer Common Stock
Mar 18, 2024 Sell 12 153 Jarrett Jennifer Common Stock
Mar 18, 2024 Sell 1 296 Jarrett Jennifer Common Stock
Feb 27, 2024 Sell 34 070 Jarrett Jennifer Common Stock
Feb 27, 2024 Sell 23 132 Jaen Juan C. Common Stock
Feb 26, 2024 Sell 24 555 Jarrett Jennifer Common Stock
Feb 26, 2024 Sell 3 900 Jaen Juan C. Common Stock
Jan 29, 2024 Buy 0 Mercier Johanna Common Stock
Jan 29, 2024 Buy 15 238 095 Gilead Sciences, Inc. Common Stock
Jan 23, 2024 Buy 22 000 Goeltz Ii Robert C. Common Stock
Jan 23, 2024 Buy 86 600 Goeltz Ii Robert C. Stock Option (right to buy)
Jan 23, 2024 Buy 21 300 Goeltz Ii Robert C. Common Stock
Jan 23, 2024 Buy 40 000 Jaen Juan C. Common Stock
Jan 23, 2024 Buy 162 400 Jaen Juan C. Stock Option (right to buy)
Jan 23, 2024 Buy 8 850 Azoy Alexander Common Stock
Jan 23, 2024 Buy 5 900 Azoy Alexander Stock Option (right to buy)
Jan 23, 2024 Buy 26 700 Tang Carolyn C. Common Stock
Jan 23, 2024 Buy 108 200 Tang Carolyn C. Stock Option (right to buy)
Jan 23, 2024 Buy 100 000 Rosen Terry J Common Stock
Jan 23, 2024 Buy 405 900 Rosen Terry J Stock Option (right to buy)
Jan 23, 2024 Buy 40 000 Jarrett Jennifer Common Stock
Jan 23, 2024 Buy 162 400 Jarrett Jennifer Stock Option (right to buy)
Jan 23, 2024 Buy 113 700 Nuyten Dimitry Sa Stock Option (right to buy)
Jan 23, 2024 Buy 28 000 Nuyten Dimitry Sa Common Stock
Jan 02, 2024 Sell 2 004 Goeltz Ii Robert C. Common Stock
Jan 02, 2024 Sell 6 975 Jaen Juan C. Common Stock
Dec 29, 2023 Buy 448 Rosen Terry J Common Stock
Dec 22, 2023 Sell 21 521 Jarrett Jennifer Common Stock
Dec 20, 2023 Sell 68 Azoy Alexander Common Stock
Dec 19, 2023 Sell 4 076 Tang Carolyn C. Common Stock
Dec 19, 2023 Sell 1 540 Nuyten Dimitry Sa Common Stock
Dec 19, 2023 Sell 661 Azoy Alexander Common Stock
Dec 19, 2023 Sell 2 808 Goeltz Ii Robert C. Common Stock
Dec 19, 2023 Sell 11 492 Jarrett Jennifer Common Stock
Dec 19, 2023 Sell 6 259 Jaen Juan C. Common Stock
Dec 19, 2023 Sell 14 000 Rosen Terry J Common Stock
Dec 18, 2023 Sell 3 991 Tang Carolyn C. Common Stock
Dec 18, 2023 Sell 1 507 Nuyten Dimitry Sa Common Stock
Dec 18, 2023 Sell 647 Azoy Alexander Common Stock
Dec 18, 2023 Sell 2 749 Goeltz Ii Robert C. Common Stock
Dec 18, 2023 Sell 11 250 Jarrett Jennifer Common Stock
Dec 18, 2023 Sell 6 128 Jaen Juan C. Common Stock
Dec 18, 2023 Sell 13 705 Rosen Terry J Common Stock
Dec 01, 2023 Sell 282 Azoy Alexander Common Stock
Sep 22, 2023 Sell 21 369 Jarrett Jennifer Common Stock
Sep 18, 2023 Sell 3 708 Nuyten Dimitry Sa Common Stock
Sep 18, 2023 Sell 12 506 Jarrett Jennifer Common Stock
Jul 28, 2023 Sell 45 000 Jarrett Jennifer Common Stock
Jul 03, 2023 Sell 1 018 Azoy Alexander Common Stock
Jun 28, 2023 Buy 1 010 000 Gilead Sciences, Inc. Common Stock
Jun 22, 2023 Sell 12 437 Jarrett Jennifer Common Stock
Jun 16, 2023 Sell 2 892 Tang Carolyn C. Common Stock
Jun 16, 2023 Sell 12 563 Jarrett Jennifer Common Stock
Jun 16, 2023 Sell 4 820 Jaen Juan C. Common Stock
Jun 16, 2023 Sell 8 762 Rosen Terry J Common Stock
Jun 15, 2023 Sell 6 000 Jaen Juan C. Common Stock
Jun 15, 2023 Buy 19 500 Lambert Nicole Stock Option (Right to Buy)
Jun 15, 2023 Buy 6 800 Lambert Nicole Common Stock
Jun 15, 2023 Buy 6 800 Perlman Andrew J Common Stock
Jun 15, 2023 Buy 19 500 Perlman Andrew J Stock Option (Right to Buy)
Jun 15, 2023 Buy 6 800 Lacey David L. Common Stock
Jun 15, 2023 Buy 19 500 Lacey David L. Stock Option (Right to Buy)
Jun 15, 2023 Buy 6 800 Ribas Antoni Common Stock
Jun 15, 2023 Buy 19 500 Ribas Antoni Stock Option (Right to Buy)
Jun 15, 2023 Buy 19 500 Machado Patrick Stock Option (Right to Buy)
Jun 15, 2023 Buy 6 800 Machado Patrick Common Stock
Jun 15, 2023 Buy 19 500 Kaneko Yasunori Stock Option (Right to Buy)
Jun 15, 2023 Buy 6 800 Kaneko Yasunori Common Stock
Jun 15, 2023 Buy 6 800 Falberg Kathryn E Common Stock
Jun 15, 2023 Sell 50 504 Falberg Kathryn E Common Stock
Jun 15, 2023 Buy 19 500 Falberg Kathryn E Stock Option (Right to Buy)
Jun 07, 2023 Sell 4 049 Goeltz Ii Robert C. Common Stock
Mar 16, 2023 Sell 8 729 Jarrett Jennifer Common Stock
Mar 09, 2023 Buy 0 Azoy Alexander Common Stock
Mar 09, 2023 Buy 0 Azoy Alexander Common Stock
Mar 09, 2023 Buy 0 Azoy Alexander Common Stock
Mar 09, 2023 Buy 0 Azoy Alexander Common Stock
Mar 09, 2023 Buy 0 Azoy Alexander Common Stock
Mar 09, 2023 Buy 87 500 Azoy Alexander Stock Option (Right to Buy)
Mar 09, 2023 Buy 867 Azoy Alexander Stock Option (Right to Buy)
Mar 09, 2023 Buy 8 500 Azoy Alexander Stock Option (Right to Buy)
Mar 09, 2023 Buy 9 500 Azoy Alexander Stock Option (Right to Buy)
Jan 27, 2023 Sell 1 600 Jarrett Jennifer Common Stock
Jan 26, 2023 Sell 300 Jarrett Jennifer Common Stock
Jan 23, 2023 Buy 138 200 Nuyten Dimitry Sa Stock Option (Right to Buy)
Jan 23, 2023 Buy 34 000 Nuyten Dimitry Sa Common Stock
Jan 23, 2023 Buy 138 200 Goeltz Ii Robert C. Stock Option (right to buy)
Jan 23, 2023 Buy 34 000 Goeltz Ii Robert C. Common Stock
Jan 23, 2023 Buy 138 200 Tang Carolyn C. Stock Option (right to buy)
Jan 23, 2023 Buy 34 000 Tang Carolyn C. Common Stock
Jan 23, 2023 Buy 45 800 Jarrett Jennifer Common Stock
Jan 23, 2023 Buy 185 900 Jarrett Jennifer Stock Option (right to buy)
Jan 23, 2023 Buy 45 800 Jaen Juan C. Common Stock
Jan 23, 2023 Buy 185 900 Jaen Juan C. Stock Option (right to buy)
Jan 23, 2023 Buy 105 700 Rosen Terry J Common Stock
Jan 23, 2023 Buy 429 000 Rosen Terry J Stock Option (right to buy)
Dec 16, 2022 Sell 2 066 Goeltz Ii Robert C. Common Stock
Dec 16, 2022 Sell 387 Goeltz Ii Robert C. Common Stock
Dec 16, 2022 Sell 2 125 Tang Carolyn C. Common Stock
Dec 16, 2022 Sell 398 Tang Carolyn C. Common Stock
INSIDER POWER
91.190
Last 100 transactions
Buy: 19 385 660 | Sell: 423 553 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 91.190.

In total, the insiders bought 19 385 660 and sold 423 553 RCUS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Arcus Biosciences Inc.

Arcus Biosciences. Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Pha... RCUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT